These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24395330)

  • 1. Imaging the inside of a tumour: a review of radionuclide imaging and theranostics targeting intracellular epitopes.
    Cornelissen B
    J Labelled Comp Radiopharm; 2014 Apr; 57(4):310-6. PubMed ID: 24395330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tapping the treasure of intracellular oncotargets with immunotherapy.
    Hong CW; Zeng Q
    FEBS Lett; 2014 Jan; 588(2):350-5. PubMed ID: 24184114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear medicine theranostics comes of age.
    Herrmann K; Kraus BJ; Hadaschik B; Kunikowska J; van Poppel H; N'Dow J; Sartor O; Oyen WJG
    Lancet Oncol; 2021 Nov; 22(11):1497-1498. PubMed ID: 34735807
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting the nucleus: an overview of Auger-electron radionuclide therapy.
    Cornelissen B; Vallis KA
    Curr Drug Discov Technol; 2010 Dec; 7(4):263-79. PubMed ID: 21034408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic antibodies to intracellular targets in cancer therapy.
    Veomett N; Dao T; Scheinberg DA
    Expert Opin Biol Ther; 2013 Nov; 13(11):1485-8. PubMed ID: 23991764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide.
    Idrissou MB; Pichard A; Tee B; Kibedi T; Poty S; Pouget JP
    Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34209637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radionuclide imaging of perfusion and hypoxia.
    Laking G; Price P
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37 Suppl 1():S20-9. PubMed ID: 20521044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo Evaluation of Auger Electron-Emitting Theranostic Radionuclides.
    Falzone N; Fernández-Varea JM; Flux G; Vallis KA
    J Nucl Med; 2015 Sep; 56(9):1441-6. PubMed ID: 26205298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery systems exploiting natural cell transport processes of macromolecules for intracellular targeting of Auger electron emitters.
    Rosenkranz AA; Slastnikova TA; Georgiev GP; Zalutsky MR; Sobolev AS
    Nucl Med Biol; 2020; 80-81():45-56. PubMed ID: 31810828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide motifs for insertion of radiolabeled biomolecules into cells and routing to the nucleus for cancer imaging or radiotherapeutic applications.
    Costantini DL; Hu M; Reilly RM
    Cancer Biother Radiopharm; 2008 Feb; 23(1):3-24. PubMed ID: 18298325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in tumour imaging. Use of radiolabelled antitumour antibodies.
    Begent RH
    Biochim Biophys Acta; 1985; 780(2):151-66. PubMed ID: 2988609
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted radionuclide therapy: frontiers in theranostics.
    Gallivanone F; Valente M; Savi A; Canevari C; Castiglioni I
    Front Biosci (Landmark Ed); 2017 Jun; 22(10):1750-1759. PubMed ID: 28410143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Illuminating the physiology of extracellular vesicles.
    Choi H; Lee DS
    Stem Cell Res Ther; 2016 Apr; 7(1):55. PubMed ID: 27084088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.
    Ting G; Chang CH; Wang HE; Lee TW
    J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20811605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy.
    van Hagen PM; Breeman WA; Bernard HF; Schaar M; Mooij CM; Srinivasan A; Schmidt MA; Krenning EP; de Jong M
    Int J Cancer; 2000 Aug; 90(4):186-98. PubMed ID: 10993959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bombesin receptor-mediated imaging and cytotoxicity: review and current status.
    Sancho V; Di Florio A; Moody TW; Jensen RT
    Curr Drug Deliv; 2011 Jan; 8(1):79-134. PubMed ID: 21034419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular effects of Auger emitters: 2008-2011.
    Yasui LS
    Int J Radiat Biol; 2012 Dec; 88(12):864-70. PubMed ID: 22694308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer care.
    Mammatas LH; Verheul HM; Hendrikse NH; Yaqub M; Lammertsma AA; Menke-van der Houven van Oordt CW
    Cell Oncol (Dordr); 2015 Feb; 38(1):49-64. PubMed ID: 25248503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
    Galili U
    Immunol Cell Biol; 2005 Dec; 83(6):674-86. PubMed ID: 16266320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-based cancer treatment with ultra-short range Auger electron-emitting radionuclides: dual receptor and DNA targeting strategies.
    Karagiannis TC
    Hell J Nucl Med; 2007; 10(3):155-9. PubMed ID: 18084655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.